The absence of a specific marker in the blood and tissues of certain monkeys may be part of the key to understanding how they can be infected for years with SIV, the primate version of HIV, and never develop AIDS, according to research published by Tulane University pathologist Ivona Pandrea in the scientific journal Blood.
Researchers at the University of Pennsylvania School of Medicine are the first to show that a mouse protein, whose human equivalent is related to defense against HIV-1, inhibits the infection and spread of a mouse tumor virus.
CNRS France and a team of Portuguese researchers at the Istitut Pasteur have just identified a protein in a micro-organism which allows it to colonise a host by modulating its immune system and may show the way to combat Group B Streptococci.
Scientists at Queensland University of Technology are one step closer to developing a world-first vaccine to protect women against contracting the most common sexually-transmitted disease, chlamydia.
Lower transplant rates in ethnic communities may be explained somewhat by a lack of suitable anonymous donors, a problem the medical community has long known and been working to address.
There is accumulating data that suggests in addition to directly killing tumor cells, reoviruses may prime the immune system to mount a separate, powerful and long lasting defense against cancer.
Four million people die every year from respiratory diseases such as viral influenza. For elderly people in particular, an infection can be dangerous.
Women who become pregnant in spring are more vulnerable to preterm birth than those who conceive in other seasons, according to researchers at the University of Pittsburgh.
It?s hard to imagine your body being attacked by foreign blood cells while your own immune system is unable to defend you.
The US National Institutes of Health has started an international study of the use of oral insulin to prevent or delay type 1 diabetes.